Market revenue in 2023 | USD 365.1 million |
Market revenue in 2030 | USD 705.8 million |
Growth rate | 9.9% (CAGR from 2023 to 2030) |
Largest segment | Adult stem cells |
Fastest growing segment | Induced Pluripotent Stem Cells |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells |
Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stem cells market will help companies and investors design strategic landscapes.
Adult stem cells was the largest segment with a revenue share of 83.59% in 2023. Horizon Databook has segmented the Spain stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
Spain is gaining a reputation in stem cell research as one of the strategically chosen drivers of its healthcare industry. As the demand for advanced therapy products is increasing in Spain, several companies and clinics are entering the country.
For instance, in April 2019, Adcure Clinic opened its new location in Madrid, Spain. The clinic has expertise in regenerative medicine, stem cell research, and physical wellness. In June 2019, Global Stem Cells Group opened a new Stem Cell Center in Valencia, Spain.
The combined use of Gene and Cell Therapy (GCT) has created an array of lucrative opportunities in Spain. The surge in the development of GCTs for the treatment of various chronic ailments is expected to boost the stem cell market in Spain.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain stem cells market , including forecasts for subscribers. This country databook contains high-level insights into Spain stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account